Opportunity ID: 250913

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-088
Funding Opportunity Title: Direct Phase II SBIR Grants to Support Biomedical Technology Development
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.121 — Oral Diseases and Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Feb 05, 2014
Last Updated Date: Feb 19, 2014
Original Closing Date for Applications: Jan 07, 2017
Current Closing Date for Applications: Jan 07, 2017
Archive Date: Feb 07, 2017
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA)
is to encourage applications to the newly authorized Direct-to-Phase II SBIR
grant mechanism.  Applications are invited from eligible United States small
business concerns (SBCs) that have demonstrated the scientific and technical
merit and feasibility of the prototype stage of developing a biomedical
technology that has commercial potential, R&D that is characteristic of
Phase-I (R43) SBIR projects.  The Direct-to-Phase II grant mechanism is
intended to facilitate SBIR-type R&D, to expand R&D opportunities for
applicant small business concerns (SBCs), and to enhance the pace of
technology development and commercialization.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Added CFDA number 93.273, per NIAAA’s participation. Feb 19, 2014
Added CFDA’s per NINDS participation. Feb 19, 2014
Feb 05, 2014

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-088
Funding Opportunity Title: Direct Phase II SBIR Grants to Support Biomedical Technology Development
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.121 — Oral Diseases and Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Feb 05, 2014
Last Updated Date: Feb 19, 2014
Original Closing Date for Applications: Jan 07, 2017
Current Closing Date for Applications: Jan 07, 2017
Archive Date: Feb 07, 2017
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA)
is to encourage applications to the newly authorized Direct-to-Phase II SBIR
grant mechanism.  Applications are invited from eligible United States small
business concerns (SBCs) that have demonstrated the scientific and technical
merit and feasibility of the prototype stage of developing a biomedical
technology that has commercial potential, R&D that is characteristic of
Phase-I (R43) SBIR projects.  The Direct-to-Phase II grant mechanism is
intended to facilitate SBIR-type R&D, to expand R&D opportunities for
applicant small business concerns (SBCs), and to enhance the pace of
technology development and commercialization.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-088
Funding Opportunity Title: Direct Phase II SBIR Grants to Support Biomedical Technology Development
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.121 — Oral Diseases and Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 19, 2014
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 07, 2017
Archive Date: Feb 07, 2017
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA)
is to encourage applications to the newly authorized Direct-to-Phase II SBIR
grant mechanism.  Applications are invited from eligible United States small
business concerns (SBCs) that have demonstrated the scientific and technical
merit and feasibility of the prototype stage of developing a biomedical
technology that has commercial potential, R&D that is characteristic of
Phase-I (R43) SBIR projects.  The Direct-to-Phase II grant mechanism is
intended to facilitate SBIR-type R&D, to expand R&D opportunities for
applicant small business concerns (SBCs), and to enhance the pace of
technology development and commercialization.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-14-088
Funding Opportunity Title: Direct Phase II SBIR Grants to Support Biomedical Technology Development
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.121 — Oral Diseases and Disorders Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 05, 2014
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 07, 2017
Archive Date: Feb 07, 2017
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA)
is to encourage applications to the newly authorized Direct-to-Phase II SBIR
grant mechanism.  Applications are invited from eligible United States small
business concerns (SBCs) that have demonstrated the scientific and technical
merit and feasibility of the prototype stage of developing a biomedical
technology that has commercial potential, R&D that is characteristic of
Phase-I (R43) SBIR projects.  The Direct-to-Phase II grant mechanism is
intended to facilitate SBIR-type R&D, to expand R&D opportunities for
applicant small business concerns (SBCs), and to enhance the pace of
technology development and commercialization.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-14-088.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00192550 Mar 05, 2014 Sep 07, 2014 View
FORMS-C Use for due dates on or after August 5, 2014 PKG00197063 Mar 05, 2014 Jun 08, 2016 View
FORMS-D Use for due dates on or after May 25, 2016 PKG00224110 Aug 05, 2016 Jan 07, 2017 View

Package 1

Mandatory forms

250913 RR_SF424_1_2-1.2.pdf

250913 PerformanceSite_1_4-1.4.pdf

250913 RR_OtherProjectInfo_1_3-1.3.pdf

250913 RR_KeyPersonExpanded_1_2-1.2.pdf

250913 RR_Budget-1.1.pdf

250913 PHS398_CoverPageSupplement_1_4-1.4.pdf

250913 PHS398_ResearchPlan_1_3-1.3.pdf

250913 PHS398_Checklist_1_3-1.3.pdf

250913 SBIR_STTR_Information_1_1-1.1.pdf

Optional forms

250913 RR_SubawardBudget30-1.2.pdf

250913 PHS_CoverLetter_1_2-1.2.pdf

Package 2

Mandatory forms

250913 RR_SF424_2_0-2.0.pdf

250913 PHS398_ResearchPlan_2_0-2.0.pdf

250913 SBIR_STTR_Information_1_1-1.1.pdf

250913 RR_KeyPersonExpanded_2_0-2.0.pdf

250913 RR_OtherProjectInfo_1_3-1.3.pdf

250913 RR_Budget_1_3-1.3.pdf

250913 PerformanceSite_2_0-2.0.pdf

250913 PHS398_CoverPageSupplement_2_0-2.0.pdf

Optional forms

250913 RR_SubawardBudget30_1_3-1.3.pdf

250913 PlannedReport-1.0.pdf

250913 PHS398_CumulativeInclusionReport-1.0.pdf

Package 3

Mandatory forms

250913 RR_SF424_2_0-2.0.pdf

250913 PHS398_CoverPageSupplement_3_0-3.0.pdf

250913 RR_OtherProjectInfo_1_3-1.3.pdf

250913 PerformanceSite_2_0-2.0.pdf

250913 RR_KeyPersonExpanded_2_0-2.0.pdf

250913 RR_Budget_1_3-1.3.pdf

250913 PHS398_ResearchPlan_3_0-3.0.pdf

250913 SBIR_STTR_Information_1_1-1.1.pdf

Optional forms

250913 RR_SubawardBudget30_1_3-1.3.pdf

250913 PHS_Inclusion_Enrollment_Report-1.0.pdf

250913 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T08:42:54-05:00

Share This Post, Choose Your Platform!

About the Author: